{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:05:29Z","timestamp":1784066729645,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["26461088"],"award-info":[{"award-number":["26461088"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijcard.2017.02.070","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T03:04:03Z","timestamp":1487905443000},"page":"162-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival"],"prefix":"10.1016","volume":"235","author":[{"given":"Keitaro","family":"Akita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-1887","authenticated-orcid":false,"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Sawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.02.070_bb0005","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.567","article-title":"Heart failure epidemiology 2000\u20132013: insights from the German Federal Health Monitoring System","volume":"18","author":"Christ","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0015","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ejhf.549","article-title":"Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients","volume":"18","author":"Farr\u00e9","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0020","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0025","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0045","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0060","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ahj.2011.10.008","article-title":"Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure","volume":"163","author":"Heidenreich","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ejhf.471","article-title":"The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database","volume":"18","author":"Maggioni","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0075","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0080","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.319","article-title":"Heart failure as a general pandemic in Asia","volume":"17","author":"Shimokawa","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0085","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0090","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/ejhf.617","article-title":"National trends in heart failure hospitalization rates in Slovenia 2004\u20132012","volume":"18","author":"Omersa","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archinternmed.2011.31","article-title":"The persistent exclusion of older patients from ongoing clinical trials regarding heart failure","volume":"171","author":"Cherubini","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0100","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.2014.10924","article-title":"Evaluation and treatment of older patients with hypercholesterolemia: a clinical review","volume":"312","author":"Strandberg","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40266-013-0095-7","article-title":"Rationalizing prescribing for older patients with multimorbidity: considering time to benefit","volume":"30","author":"Holmes","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M14-1430","article-title":"Cost-effectiveness and population impact of statins for primary prevention in adults aged 75years or older in the United States","volume":"162","author":"Odden","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0120","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCHEARTFAILURE.114.001734","article-title":"Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction","volume":"8","author":"Takei","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2015.10.008","article-title":"Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level","volume":"171","author":"Shiraishi","year":"2016","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0135","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1253\/circj.CJ-11-0267","article-title":"Predictors of long-term adverse outcomes in elderly patients over 80years hospitalized with heart failure","volume":"75","author":"Hamaguchi","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehn539","article-title":"Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II","volume":"30","author":"Komajda","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0145","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2009.04.011","article-title":"Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: results from the Italian Survey on Acute Heart Failure","volume":"158","author":"Miani","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0155","first-page":"608","article-title":"Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain","volume":"13","author":"Nishiguchi","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0160","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(11)60828-3","article-title":"Japanese universal health coverage: evolution, achievements, and challenges","volume":"378","author":"Ikegami","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1253\/circj.72.489","article-title":"Impending epidemic: future projection of heart failure in Japan to the year 2055","volume":"72","author":"Okura","year":"2008","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2010.03.019","article-title":"Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data","volume":"159","author":"Sato","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/eurheartj\/ehl443","article-title":"Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I","volume":"28","author":"Komajda","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0180","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/heart.88.4.373","article-title":"Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial","volume":"88","author":"Hutcheon","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0195","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ejheart.2008.09.009","volume":"10","author":"Rossi","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2125.2006.02769.x","article-title":"Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?","volume":"63","author":"Dobre","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0205","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.07.018","article-title":"Long-term use of cardiovascular drugs: challenges for research and for patient care","volume":"66","author":"Rossello","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7861\/clinmedicine.15-1-47","article-title":"Drug therapies in older adults (part 1)","volume":"15","author":"Mukhtar","year":"2015","journal-title":"Clin. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ejhf.529","article-title":"Has the 'epidemic' of heart failure been replaced by a tsunami of co-morbidities?","volume":"18","author":"Jhund","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1745-6215-13-25","article-title":"Is there benefit in optimising heart failure treatment in over-80year-old patients? (HF-80 study): study protocol for a randomized controlled trial","volume":"13","author":"Eschalier","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2017.02.070_bb0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ejhf.518","article-title":"Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure","volume":"18","author":"Vid\u00e1n","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0240","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.02.070_bb0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/CLEP.S44560","article-title":"Cognitive impairment and self-care in heart failure","volume":"5","author":"Hajduk","year":"2013","journal-title":"Clin Epidemiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317310987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317310987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:54:30Z","timestamp":1536015270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317310987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":49,"alternative-id":["S0167527317310987"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.070","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}